Dec 28, 2025 | News
Researchers at Hemera, including co-founders Ilaria Decimo and Francesco Bifari and senior scientist Sissi Dolci, have published a key study in STAR Protocols by Cell Press, essential for the development of REMaST®, our advanced cell therapy for nervous tissue...
Dec 15, 2025 | News
Il Sole 24 Ore insert dedicated to the BFactor Award by the Fondazione Marisa Bellisario was released, featuring a profile of the winners. Among them, Cristiana Vignoli, CEO of Hemera, shared her entrepreneurial vision and the journey that led to the development of...
Dec 11, 2025 | News
Hemera is pleased to announce the appointment of Michela Pantaleoni to its Board of Directors. Michela brings over twenty years of experience in the Life Sciences sector, with deep expertise in the launch and market access of innovative therapies, particularly in...
Dec 4, 2025 | News
Hemera was featured on the TG2 national TV programme “Tutto il bello che c’è”, aired on Thursday 4 December at 1:30 pm, with an interview with Cristiana Vignoli, CEO of Hemera, following her recent award of the Bfactor Award promoted by the Fondazione Marisa...
Dec 3, 2025 | News
Cristiana Vignoli, CEO of Hemera, has been appointed Sole Director of Proemera, the main investment vehicle supporting Hemera since its foundation. The appointment strengthens the strategic link between the two organizations and helps ensure continuity of vision and...
Oct 18, 2025 | News
Cristiana Vignoli, CEO of Hemera, has been awarded the BFactor 2025 Prize as part of the fifth edition of the initiative promoted by the Marisa Bellisario Foundation, under the High Patronage of the European Parliament, the Italian Chamber of Deputies, the Presidency...
